A Study of the Pharmacokinetics and Immunologic Effects of Lipoic Acid in Multiple Sclerosis
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn about an investigational drug known as oral lipoic acid
(LA) that may help treat multiple sclerosis. This study will measure how a person's body
absorbs and breaks down the drug (pharmacokinetics) and will compare four different forms of
the drug from four different manufacturers as well as LA in conjunction with fish oil.
Phase:
Phase 1
Details
Lead Sponsor:
Oregon Health and Science University
Collaborator:
National Center for Complementary and Integrative Health (NCCIH)